1-9 of 9
Geoff Chong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress: Treatment of Newly-Diagnosed Follicular Lymphoma with Celmod BMS-986369, Rituximab +/- Nivolumab: An Umbrella Phase II Investigator-Initiated Study

Geoff Chong, Jodie B Palmer, Allison A Barraclough, Leonid Churilov, Colm Keane, Sze Ting Lee, Denise Lee, Sumita Ratnasingam, Charmaine Smith, Eliza A Hawkes
Journal: Blood
Blood (2023) 142 (Supplement 1): 3051.
https://doi.org/10.1182/blood-2023-173110
Published: 2023
Journal Articles

Immune Priming with Single-Agent Nivolumab Followed By Combined Nivolumab & Rituximab Is Safe and Efficacious for First-Line Treatment of Follicular Lymphoma; Interim Analysis of the '1 st FLOR' Study

Allison Barraclough, Geoff Chong, Michael Gilbertson, Andrew Grigg, Leonid Churilov, Tineke Fancourt, David Ritchie, MD PhD, Rachel Koldej, Rishu Agarwal, Kate Manos, Charmaine Smith, Kristen Houdyk, Joanne Hawking, Eliza Hawkes
Journal: Blood
Blood (2019) 134 (Supplement_1): 1523.
https://doi.org/10.1182/blood-2019-123908
Published: 2019
Journal Articles

Phase I Dose Escalation Study of Radiotherapy and Durvalumab (MEDI4736) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): The RaDD Study

Eliza A Hawkes, Kate Manos, Geoff Chong, Jodie Palmer, Michael MacManus, Colm Keane, MD, Andrew Scott, Jake Shortt, MBBS FRACP FRCPA PhD, David Ritchie, MD PhD, Leonid Churilov, Laura Johnston, Tom Witkowski, Allison Barraclough, Sze-Ting Lee, Wendi Lin, Rachel Koldej, Richard Khor
Journal: Blood
Blood (2019) 134 (Supplement_1): 5328.
https://doi.org/10.1182/blood-2019-122635
Published: 2019
Journal Articles

AvR-CHOP: Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Eliza A Hawkes, Kate Manos, MBBS, Charmaine Smith, Joanne Hawking, Stephanie O'Brien, Leonid Churilov, Joseph McKendrick, William Renwick, Andrew Grigg, Tom Witkowski, Andrew Scott, Sze-Ting Lee, Wendi Lin, Chun Fong, Carmela Rooney, Allison Barraclough, Joel Wight, Geoff Chong
Journal: Blood
Blood (2019) 134 (Supplement_1): 5332.
https://doi.org/10.1182/blood-2019-127858
Published: 2019
Journal Articles

A Multicenter Retrospective Review of Outcomes of Diffuse Large B Cell Lymphoma (DLBCL) in the Elderly Treated with RCHOP in Australia

Michael D Ashby, MBBS, Eliza A Hawkes, FRACP, MBBS, Andrew P Grigg, MBBS, MD FRACP, FRCPA, Grace Gard, MBBS, Zi Yun Ng, MBBS, Huayi Ellen Huang, Chan Yoon Cheah, Zoe Loh, MBBS, Allison Mo, MD, Geoff Chong, MD, Andrew B M Lim
Journal: Blood
Blood (2017) 130 (Supplement 1): 4143.
https://doi.org/10.1182/blood.V130.Suppl_1.4143.4143
Published: 2017
Journal Articles

Limited Utility of Routine Chest X-Ray (CXR) in Initial Evaluation of Febrile Neutropenia in Patients with Haematological Diseases Undergoing Chemotherapy

Ortis Estacio, Zoe Loh, Andrew Grigg, MBBS, MD FRACP, FRCPA, Amy Baker, Leonid Churilov, Geoff Chong, MD, Eliza A Hawkes
Journal: Blood
Blood (2016) 128 (22): 3549.
https://doi.org/10.1182/blood.V128.22.3549.3549
Published: 2016
Journal Articles

Routine Blood Investigations Have Limited Utility in Routine Surveillance of High-Grade Lymphomas (HGL) in Remission after First-Line Therapy

Zoe Loh, Leigh Beveridge, MBBS, Andrew P Grigg, MBBS MD, Ortis Estacio, Geoff Chong, MD, Francis Ha, Michael Gilbertson, Eliza A Hawkes
Journal: Blood
Blood (2016) 128 (22): 3040.
https://doi.org/10.1182/blood.V128.22.3040.3040
Published: 2016
Journal Articles

Patient Selection for High-Dose Methotrexate As Central Nervous System Prophylaxis in Diffuse Large B-Cell Lymphoma in Australia: Are We Getting It Right?

Melissa Garwood, Eliza A Hawkes, Leonid Churilov, Andrew Grigg, MBBS, MD FRACP, FRCPA, Geoff Chong, MD
Journal: Blood
Blood (2016) 128 (22): 4217.
https://doi.org/10.1182/blood.V128.22.4217.4217
Published: 2016
Journal Articles

Early Treatment Intensification with R-ICE Chemotherapy Followed By Autologous Stem Cell Transplantation (ASCT) Using Zevalin-BEAM for Patients with Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL) As Identified By Interim PET/CT Scan Performed after Four Cycles of R-CHOP-14: A Multicenter Phase II Study of the Australasian Leukaemia Lymphoma Study Group (ALLG)

Mark S Hertzberg, MBBS PhDFRACP FRCPA, Maher K Gandhi, PhDFRACP FRCPath FRCP, Belinda Butcher, BSc MBiostat PhDCMPP, Ruth Columbus, BSc PhD, John Taper, MBBS FRACP FRCPA, Judith Trotman, MBChB, Devinder Gill, MB FRCPath FRACP FRCPA, Shir-Jing Ho, MBBS FRACP FRCPA, Keith Fay, MBChB FRACP FRCPA, Gavin Cull, MBBS DM FRACP FRCPA, Andrew P Grigg, MBBS MD, Geoff Chong, MBBS FRACP, Ian D. Lewis, MBBS PhDFRACP FRCPA, Sam Milliken, MBBS FRACP FRCPA, William Renwick, Uwe Hahn, MBBS FRACP FRCPA, Robin Filshie, PhDFRACP FRCPA, Anne-Marie Watson, MBBS FRACP FRCPA, George Kannourakis, MD PhD, Max Wolf, MBBS FRACP FRCPA, Andrew Wirth, MBBS, Pauline Therese Warburton, MBBS PhDFRACP FRCPA, Stephen Robert Larsen, MBBS PhDFRCPA FRACP, John F. Seymour, MBBS, PhD, Rodney Hicks, MBBS FRACP
Journal: Blood
Blood (2015) 126 (23): 815.
https://doi.org/10.1182/blood.V126.23.815.815
Published: 2015